Guidance for RTI Biologics, Inc. (RTIX)
Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
---|---|---|---|---|---|---|
2018 | N/A | N/A | $280.00M – 290.00M | $281.07M | = Maintained | Details |
2018 | N/A | N/A | $280.00M – 290.00M | $283.35M | = Maintained | Details |
2018 | N/A | N/A | $280.00M – 290.00M | $283.66M | = Maintained | Details |
2018 | N/A | N/A | $280.00M | $283.50M | = Maintained | Details |
2017 | $0.04 – $0.08 | $0.08 | $274.00M – 280.00M | $281.39M | = Maintained | Details |
Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
2016 | $0.18 – $0.21 | $0.23 | $280.00M – 290.00M | $288.50M | = Maintained | Details |
Q1 2016 | N/A | N/A | $65.00M – 66.00M | $69.70M | = Maintained | Details |
2015 | $0.17 – $0.22 | $0.17 | $278.00M – 285.00M | $278.50M | = Maintained | Details |
2015 | $0.19 – $0.23 | $0.19 | $281.00M – 286.00M | $283.10M | Raised | Details |
2015 | $0.20 – $0.23 | $0.21 | $282.00M – 286.00M | $284.40M | = Maintained | Details |
2015 | $0.19 | $0.21 | $274.00M – 275.00M | $284.50M | = Maintained | Details |
Q4 2015 | $0.05 | $0.07 | $68.00M – 69.00M | $75.00M | = Maintained | Details |
Q2 2015 | $0.04 | $0.04 | $70.00M – 71.00M | $70.10M | = Maintained | Details |
2014 | $0.07 – $0.09 | $0.07 | $248.00M – 253.00M | $236.80M | Raised | Details |
2014 | $0.11 | $0.10 | $260.00M – 261.00M | $249.13M | Raised | Details |
Q4 2014 | $0.04 | $0.04 | $68.00M – 69.00M | $65.13M | = Maintained | Details |
2013 | N/A | N/A | $42.00M – 43.00M | $43.20M | = Maintained | Details |
2013 | $0.00 | $0.03 | $59.00M – 61.00M | $49.90M | = Maintained | Details |
2013 | $0.17 – $0.19 | $0.17 | $179.00M – 182.00M | $178.30M | Raised | Details |
2013 | ($0.28) | $0.05 | $196.00M – 197.00M | $203.15M | = Maintained | Details |
2013 | $0.17 – $0.19 | $0.22 | $178.00M – 182.00M | $188.39M | = Maintained | Details |
2013 | $0.05 – $0.07 | $0.17 | $211.00M – 215.00M | $186.32M | = Maintained | Details |
Q4 2013 | ($0.09) | $0.03 | $59.00M – 60.00M | $68.26M | = Maintained | Details |
Q1 2013 | $0.02 | $0.05 | $38.00M – 39.00M | $45.90M | = Maintained | Details |
2012 | $0.16 – $0.17 | $0.16 | $176.00M – 178.00M | $175.70M | Raised | Details |
2012 | $0.15 – $0.17 | $0.18 | $174.00M – 176.00M | $175.84M | = Maintained | Details |
2012 | $0.14 – $0.15 | $0.17 | $177.00M – 178.00M | $177.24M | Raised | Details |
Q3 2012 | N/A | N/A | $44.00M – 45.00M | $43.49M | = Maintained | Details |
Q2 2012 | $0.04 | $0.04 | $43.00M – 44.00M | $44.18M | = Maintained | Details |
Q1 2012 | $0.03 | $0.04 | $41.00M – 42.00M | $42.46M | = Maintained | Details |
2011 | $0.11 – $0.13 | $0.10 | $159.00M – 162.00M | $165.81M | = Maintained | Details |
2011 | $0.12 – $0.14 | $0.12 | $164.00M – 166.00M | $161.79M | Raised | Details |
2011 | $0.12 – $0.14 | $0.13 | $164.00M – 166.00M | $165.94M | = Maintained | Details |
Q3 2011 | $0.03 | $0.03 | $40.00M – 41.00M | $38.98M | = Maintained | Details |
Q2 2011 | $0.03 | $0.03 | $40.00M – 41.00M | $40.03M | = Maintained | Details |
Q1 2011 | $0.02 | $0.03 | $38.00M – 39.00M | $40.02M | = Maintained | Details |